https://twitter.com/Kevin_McKernan/status/1743233076694757549
Kevin McKernan
@Kevin_McKernan
To all the fact checkers.
If you can’t address the nuclear targeting sequence in SV40 (Dean et al)….
And the evidence that this sequence binds to the p53 tumor suppressor gene (Drayman et al).
..
You are wasting everyone’s time
From anandamide.substack.com
5:28 AM · Jan 5, 2024
Dr Clare Craig
@ClareCraigPath
There was no trial on the drug given to the public - the mass produced version.
To appease the regulators Pfizer agreed to a comparison study of the different manufacturing sites against a control group (presumably the drug used in the trial).
The control group was removed on 9th Feb 2021.
The "objective to describe the safety and immunogenicity of prophylactic BNT162b2 …produced by manufacturing "process 2"" was dropped in September 2022.
https://classic.clinicaltrials.gov/ct2/history/NCT04713553?B=2&A=1&C=merged#StudyPageTop
Quote
a_concerned_amyloidosis💜🐭🇩🇪
@a_nineties
·
Dec 28, 2023
Replying to @a_nineties
and just to tie it all up nicely, protocol amendment 20 of C4591001 reveals that they just closed up shop along with cancelling the process 1/2 clinical comparison 😉
5:20 AM · Jan 5, 2024
·
https://twitter.com/ClareCraigPath/status/1743230869198823721